Parkinson's disease: the first common neurological disease due to auto-intoxication?

被引:38
|
作者
Williams, AC
Cartwright, LS
Ramsden, DB [1 ]
机构
[1] Univ Birmingham, Div Neurosci, Birmingham, W Midlands, England
[2] Univ Birmingham, Div Med Sci, Birmingham, W Midlands, England
关键词
D O I
10.1093/qjmed/hci027
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Parkinson's disease may be a disease of autointoxication. N-methylated pyridines (e.g. MPP+) are well-established dopaminergic toxins, and the xenobiotic enzyme nicotinamide N-methyltransferase (NNMT) can convert pyridines such as 4-phenylpyridine into MPP+, using S-adenosyl methionine (SAM) as the methyl donor. NNMT has recently been shown to be present in the human brain, a necessity for neurotoxicity, because charged compounds cannot cross the blood-brain barrier. Moreover, it is present in increased concentration in parkinsonian brain. This increase may be part genetic predisposition, and part induction, by excessive exposure to its substrates (particularly nicotinamide) or stress. Elevated enzymic activity would increase MPP+-like compounds such as N-methyl nicotinamide at the same time as decreasing intraneuronal nicotinamide, a neuroprotectant at several levels, creating multiple hits, because Complex 1 would be poisoned and be starved of its major substrate NADH. Developing xenobiotic enzyme inhibitors of NNMT for individuals, or dietary modification for the whole population, could be an important change in thinking on primary and secondary prevention.
引用
收藏
页码:215 / 226
页数:12
相关论文
共 50 条
  • [11] IncobotulinumtoxinA for treating chronic sialorrhea due to Parkinson's disease and other neurological conditions
    Jost, W.
    Pagan, F.
    MOVEMENT DISORDERS, 2022, 37 : S453 - S454
  • [12] Population genetic approaches to neurological disease: Parkinson's disease as an example
    Gandhi, S
    Abou-Sleiman, PM
    Healy, DG
    Weale, M
    Gilks, W
    Ahmadi, K
    Goldstein, DB
    Wood, NW
    PHILOSOPHICAL TRANSACTIONS OF THE ROYAL SOCIETY B-BIOLOGICAL SCIENCES, 2005, 360 (1460) : 1573 - 1578
  • [14] Olfactory Dysfunction in Parkinson's Disease and other Neurological Disorders: Identification of a Common Pathological Substrate?
    Doty, R. L.
    MOVEMENT DISORDERS, 2017, 32 (09) : E7 - E7
  • [15] Neurological Insights into Sleep Disorders in Parkinson's Disease
    Thangaleela, Subramanian
    Sivamaruthi, Bhagavathi Sundaram
    Kesika, Periyanaina
    Mariappan, Subramanian
    Rashmi, Subramanian
    Choeisoongnern, Thiwanya
    Sittiprapaporn, Phakkharawat
    Chaiyasut, Chaiyavat
    BRAIN SCIENCES, 2023, 13 (08)
  • [16] The Geriatric Patient with Parkinson's Disease - a Neurological Challenge
    Lingor, P.
    Csoti, I.
    Koschel, J.
    Schrader, C.
    Winkler, C.
    Wolz, M.
    Reichmann, H.
    FORTSCHRITTE DER NEUROLOGIE PSYCHIATRIE, 2016, 84 : S41 - S47
  • [17] Functional Neurological Symptoms Associated With Parkinson's Disease
    Gupta, Rishab
    Harder, Jessica
    JOURNAL OF NEUROPSYCHIATRY AND CLINICAL NEUROSCIENCES, 2021, 33 (03) : 242 - 243
  • [18] Parkinson's Disease is becoming more common
    不详
    DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 2016, 141 (14) : 993 - 993
  • [19] Dementia in Parkinson's disease: common and treatable
    McKeith, I
    LANCET NEUROLOGY, 2004, 3 (08): : 456 - 456
  • [20] How common are complications of Parkinson's disease?
    Anette Schrag
    Yoav Ben-Shlomo
    Niall Quinn
    Journal of Neurology, 2002, 249 : 419 - 423